Integration of the Mapi Group has been initiated, Icon CEO Steve Cutler says, as the company looks to support customers facing increased pressure to demonstrate product value and safety.
This month’s roundup includes two new CEOs and a VP at Quanterix who will lead the company’s biomarker research, custom assay development, and clinical sample testing lab.